Lab901 to Present at-line Monitoring Solutions at BioProcess International 2010
News May 18, 2010
Lab901 will present their Protein ScreenTape® platform at BioProcess International, which can deliver practical at-line monitoring of monoclonal antibody production.
Prior to the launch of ScreenTape at-line monitoring of antibody production by SDS PAGE has been impractical due to the high cost per test-point and long analysis time.
According to Company, with its rapid staining protocol and automated sample handling, electrophoresis and data presentation, the Protein ScreenTape platform can deliver information on yield, purity and molecular weight within a few minutes. Samples can be analyzed directly from the bioreactor with no need to purify or filter the media. Analysis of media containing high levels of serum is also possible using Protein ScreenTape.
Lab901 application scientist, Adam Inche, said “It is now possible to assess antibody production by SDS-PAGE on a day-by-day, or even hour-by-hour basis, making this information invaluable not only for process optimization, but also for batch monitoring. Using this data our clients will be able to make more informed decisions on when to harvest their bioreaction batch, thereby saving them time and money.”
New Drug to Treat Herpes Simplex Virus Infection?News
Researchers have now identified a small drug molecule that can clear the HSV-1 infection in the cells of the cornea -- the clear outer layer of the eyeball -- and works completely differently than the currently-available drugs, making it a promising potential option for patients who have developed resistance.READ MORE
Lonza to Establish Cell- and Gene-Therapy Centers of Excellence to Accelerate GrowthNews
Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company.READ MORE